panitumumab,bevacizumab
amgen,takeda,roche
[]
now, pmab vs bev in left sided ras wt colon cancer - 36+ months median survival. but looking at curves, despite positive trial, i am not that impressed. curves are together/criss-cross until around/at 30 months i think we need to discuss this one #asco22 
Chief MedOnc @SylvesterCancer. Helping improve Cancer Control in LMICs. Editor-in-Chief @JCOGO_ASCO, Board Member @UICC - co-chair #ATOMcoalition